Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 71.9% in March

Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 134,600 shares, a growth of 71.9% from the February 28th total of 78,300 shares. Based on an average daily volume of 2,000 shares, the short-interest ratio is currently 67.3 days. Approximately 0.1% of the shares of the stock are short sold.

Oxford Biomedica Price Performance

Oxford Biomedica stock remained flat at $3.88 on Wednesday. The business has a fifty day simple moving average of $4.45 and a two-hundred day simple moving average of $4.92. Oxford Biomedica has a fifty-two week low of $2.44 and a fifty-two week high of $5.68. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.